Search for Clinical Trial Results
Iron Overload - 26 Studies Found
Status | Study |
Completed |
Study Name: A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity Condition: Transfusional Iron Overload Date: 2010-01-05 Interventions: Drug: ICL670 |
Completed |
Study Name: A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload Condition: Transfusion-dependent Iron Overload Date: 2005-09-13 Interventions: Drug: Deferasirox Other Name: ICL670 |
Terminated |
Study Name: Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy Condition: Iron Overload Due to Repeated Red Blood Cell Transfusions Date: 2012-05-22 Interventions: Drug: SPD602 50 mg/kg/day orally twice daily for 24 weeks |
Completed |
Study Name: An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload Condition: Transfusional Iron Overload in β-thalassemia Date: 2005-09-12 Interventions: Drug: Deferasirox Tablets taken orally once a day. |
Completed |
Study Name: Iron Overload in African Americans Condition:
Date: 1999-11-03 |
Completed |
Study Name: Cytochrome P450 2E1 and Iron Overload Condition:
Date: 2005-08-29 Interventions: Procedure: venesection Venesection therapy is realised every 7 - 14 days until iron desaturation complet |
Completed |
Study Name: Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients Condition:
Date: 2011-05-17 Interventions:
|
Completed |
Study Name: Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox Therapy Condition: Iron Overload Date: 2013-05-26 |
Completed |
Study Name: Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major Condition:
Date: 2011-07-11 Interventions: Drug: Amlodipine 5mg PO initially; may be reduced to 2.5mg PO if side effects |
Recruiting |
Study Name: Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis Condition:
|